Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Increases Investment in Rosetta Biosoftware

NEW YORK, Aug. 23 (GenomeWeb News) - Agilent Technologies has increased its investment in Rosetta Biosoftware, the companies said today.


An Agilent spokeswoman said that the financial details of the investment are not being disclosed.


Agilent is the exclusive distributor of the Rosetta Resolver and Rosetta Luminator gene-expression data analysis systems.


The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.